BioInformant

Your Global Leader in Stem Cell Market Research

Home » Unicyte

Top Companies Developing Cell Therapy Treatments For Diabetes

By

Below is a list of the top companies exploring cell therapy treatments for diabetes.

In this article:

[Read more…]

Unicyte and Collaboration Partner Prof. Camussi Achieve Preclinical Milestone in Diabetes Program

By

Unicyte, a regenerative medicine unit of Fresenius Medical Care, and its collaboration partner Professor Camussi have published results in Stem Cell Reviews and Reports that a potential therapeutic strategy for diabetes is the transplantation of induced-insulin secreting cells.

The Global Disease Burden of Diabetes Mellitus

Diabetes mellitus is one of the most common diseases globally. Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. With an aging population and surging rates of obesity, the incidence of this debilitating disease on the rise. [Read more…]

Fresenius Medical Care achieves preclinical milestone in its regenerative medicine program for chronic kidney disease

By

Unicyte

July 30, 2018 – Fresenius Medical Care, the world’s largest provider of dialysis products and services, announced today that its subsidiary Unicyte AG has achieved a key preclinical milestone in its regenerative medicine program for chronic kidney disease. The company was able to confirm a disease modifying potential for its proprietary nano-Extracellular Vesicles (“nEVs” are stem cell-derived particles that support communication between cells) in a second preclinical model of chronic kidney disease. [Read more…]

BioInformant's World-Class Clients